Citation Tools

Download PDFPDF

Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma

Download to a citation manager

Cite this article as:
Smithy JW, Moore LM, Pelekanou V, et al
Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma